Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
54,486,781
-
Number of holders
-
234
-
Total 13F shares, excl. options
-
40,397,491
-
Shares change
-
+3,253,130
-
Total reported value, excl. options
-
$1,878,364,516
-
Value change
-
+$151,859,986
-
Put/Call ratio
-
190%
-
Number of buys
-
144
-
Number of sells
-
71
-
Price
-
$46.47
Institutional Holders of Emergent BioSolutions Inc. - Common Stock (EBS) as of Q4 2017
As of 31 Dec 2017 Emergent BioSolutions Inc. - Common Stock (EBS) had 234 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 40,397,491 shares of stock of the company.
Largest 10 holders included BlackRock Inc., Vanguard Group Inc, DIMENSIONAL FUND ADVISORS LP, Standard Life Aberdeen plc, RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, ACADIAN ASSET MANAGEMENT LLC, ROYAL BANK OF CANADA, SNYDER CAPITAL MANAGEMENT L P, and NORTHERN TRUST CORP.
This table shows 234 institutional shareholders of the security as of 31 Dec 2017.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.